It is also believed to have direct anti-inflammatory effects by inhibiting nuclear factor κB (NF-κB) activation and reducing the release of inflammatory cytokines like interleukin-6 (IL-6), as well as indirectly by lowering hyperglycemia and insulin levels [110]. The gene discussed is NFKB1; the disease is Hyperglycemia.